Does elevated homocysteine increase cardiovascular disease risk?

Elevated homocysteine (Hcy), a sulfur-containing amino acid derivative of methionine metabolism, has long been investigated as a potent biomarker for vascular health. In older populations and specifically in males, monitoring these levels is particularly relevant as physiological changes in vitamin B12 and folate metabolism often lead to higher circulating concentrations.

Clinical evidence of cardiovascular risk

Epidemiological research consistently identifies hyperhomocysteinemia as an independent risk factor for adverse cardiovascular outcomes. Large-scale meta-analyses of prospective studies, encompassing over 23,000 subjects, have demonstrated that individuals in the highest Hcy quartiles experience a 66% increased risk of coronary heart disease (CHD) mortality and a 68% increase in overall cardiovascular mortality. Genetic evidence further reinforces this link; studies on the MTHFR C677T polymorphism—which naturally elevates Hcy—show an odds ratio for ischemic heart disease ranging from 1.32 to 1.42 for every 5 μmol/L increase in Hcy, closely mirroring the risk seen in observational cohorts.

Mechanistic pathways

The deleterious effects of elevated Hcy are driven by complex cellular disruptions:

• Oxidative Stress and ER Stress: High levels of Hcy trigger endoplasmic reticulum (ER) stress, leading to the overproduction of reactive oxygen species (ROS).
• Endothelial Dysfunction: ROS production reduces nitric oxide (NO) bioavailability by scavenging NO and uncoupling endothelial NO synthase (eNOS). This impairs the ability of blood vessels to dilate properly.
• Vascular Inflammation: In older adults, these biochemical stresses are often amplified by age-related inflammatory states, accelerating the progression of atherosclerosis and increasing the likelihood of acute vascular events.

Bottom line

Elevated homocysteine is a robust, independent risk factor for cardiovascular disease. For an elderly male, maintaining optimal Hcy levels is critical for preserving endothelial function and reducing the long-term risk of coronary and cardiovascular mortality.